QCM
ALNY icon

Quantinno Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quantinno Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2M Buy
33,850
+8,258
+32% +$2.81M 0.02% 830
2025
Q4 		$10.2M Buy
25,592
+6,327
+33% +$2.8M 0.02% 773
2025
Q3 		$8.79M Buy
19,265
+5,801
+43% +$2.36M 0.02% 712
2025
Q2 		$4.39M Buy
13,464
+7,032
+109% +$1.95M 0.02% 859
2025
Q1 		$1.74M Buy
6,432
+1,876
+41% +$482K 0.01% 1015
2024
Q4 		$1.07M Buy
4,556
+1,190
+35% +$313K 0.01% 1034
2024
Q3 		$926K Buy
3,366
+1,126
+50% +$293K 0.01% 962
2024
Q2 		$544K Buy
+2,240
New +$354K 0.01% 1010

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return